Louisiana Federal Court Consents to Assignment of the Taxotere Hair-Loss Litigation

Taxotere Hair Loss Litigation

On October 3, 2016, the U.S. District Court for the Eastern District of Louisiana consented to assignment of the actions alleging that the chemotherapy drug, Taxotere, can cause permanent hair loss, particularly in those being treated for breast cancer, to the Honorable Lance M. Africk for coordinated or consolidated pretrial proceedings. As previously reported in...

Read More

Taxotere® Litigation: Ohio Breast Cancer Survivor Now Takes On Sanofi-Aventis

Pharmaceutical litigation

Temporary hair loss following chemotherapy is hard enough. Unfortunately, as acknowledged by the FDA, cases of permanent hair loss (alopecia) have been reported in patients who have been given the chemotherapy drug, Taxotere®. Now a breast cancer survivor from Ohio, Hattie Carson, has decided to take on Sanofi-Aventis in Ohio Federal Court. According to her complaint, Ms. Carson underwent...

Read More